S100A4 and neoplasm: Immunohistochemical results were consistent with in vitro, and elevated RP11-54O7.17 significantly reduced the protein content of S100A4, p-STAT3 and Ki-67 in tumor tissues (Fig. 8G) and suppressed the expression of p-STAT3 and S100A4 (Fig. 8H).